FPR1

formyl peptide receptor 1, the group of Formyl peptide receptors

Basic information

Region (hg38): 19:51745172-51804115

Links

ENSG00000171051NCBI:2357OMIM:136537HGNC:3826Uniprot:P21462AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Tourette syndrome (No Known Disease Relationship), mode of inheritance: Unknown
  • susceptibility to localized juvenile periodontitis (Supportive), mode of inheritance: AR

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FPR1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FPR1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
66
clinvar
8
clinvar
75
missense
114
clinvar
7
clinvar
8
clinvar
129
nonsense
2
clinvar
2
start loss
0
frameshift
2
clinvar
2
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 119 73 16

Variants in FPR1

This is a list of pathogenic ClinVar variants found in the FPR1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-51745951-C-T Gingival disorder Likely benign (Aug 11, 2023)1132842
19-51745957-C-T FPR1-related disorder Likely benign (Oct 28, 2019)3040106
19-51745957-CT-TG Gingival disorder Benign (Jan 19, 2024)526513
19-51745958-T-G not specified • Gingival disorder Benign (Feb 01, 2024)402874
19-51745979-G-A Gingival disorder Uncertain significance (Oct 22, 2023)1480296
19-51745980-T-C Gingival disorder Uncertain significance (Mar 02, 2023)2842265
19-51745985-T-C Gingival disorder Uncertain significance (Feb 24, 2023)2788195
19-51745987-G-A Gingival disorder Likely benign (Feb 22, 2022)2102104
19-51745987-G-T Gingival disorder Likely benign (Jan 21, 2024)2073976
19-51746002-G-A not specified • Gingival disorder Benign (Jan 31, 2024)402875
19-51746013-A-G Gingival disorder • not specified Uncertain significance (Dec 06, 2022)2147975
19-51746019-C-T Gingival disorder Uncertain significance (Aug 04, 2023)1009944
19-51746020-G-C Gingival disorder Likely benign (Jul 05, 2022)1614672
19-51746026-G-A Gingival disorder Likely benign (Feb 06, 2020)1086962
19-51746035-C-T Gingival disorder Likely benign (Aug 23, 2022)2017348
19-51746038-A-G Gingival disorder Likely benign (Jan 21, 2024)1125926
19-51746040-T-G Gingival disorder Uncertain significance (Sep 02, 2021)847520
19-51746041-G-C Gingival disorder Likely benign (Aug 06, 2020)1138308
19-51746043-C-T Gingival disorder Uncertain significance (Jan 29, 2024)840695
19-51746052-C-T Gingival disorder Uncertain significance (Jul 22, 2021)958537
19-51746053-G-A Gingival disorder Likely benign (May 29, 2023)1153606
19-51746061-G-A Gingival disorder Likely benign (Nov 28, 2023)848388
19-51746069-C-T Gingival disorder Uncertain significance (Sep 27, 2023)1036271
19-51746076-C-T Gingival disorder Uncertain significance (Aug 14, 2019)960581
19-51746077-C-T Gingival disorder Likely benign (Aug 02, 2023)2876451

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FPR1protein_codingprotein_codingENST00000595042 158939
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5521812030.8910.00001242274
Missense in Polyphen4351.5740.83375677
Synonymous-1.7910281.51.250.00000530760
Loss of Function

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish
East Asian
Finnish
European (Non-Finnish)
Middle Eastern
South Asian
Other

dbNSFP

Source: dbNSFP

Function
FUNCTION: High affinity receptor for N-formyl-methionyl peptides (fMLP), which are powerful neutrophil chemotactic factors (PubMed:2161213, PubMed:2176894, PubMed:10514456, PubMed:15153520). Binding of fMLP to the receptor stimulates intracellular calcium mobilization and superoxide anion release (PubMed:2161213, PubMed:1712023, PubMed:15153520). This response is mediated via a G-protein that activates a phosphatidylinositol- calcium second messenger system (PubMed:1712023, PubMed:10514456). {ECO:0000269|PubMed:10514456, ECO:0000269|PubMed:15153520, ECO:0000269|PubMed:2161213, ECO:0000269|PubMed:2176894, ECO:0000303|PubMed:10514456, ECO:0000303|PubMed:1712023, ECO:0000303|PubMed:2161213, ECO:0000303|PubMed:2176894}.;
Pathway
Staphylococcus aureus infection - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Peptide GPCRs;Human Complement System;Interleukin-10 signaling;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Neutrophil degranulation;Signal Transduction;ion channels and their functional role in vascular endothelium;activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor;chrebp regulation by carbohydrates and camp;role of -arrestins in the activation and targeting of map kinases;activation of camp-dependent protein kinase pka;Innate Immune System;Immune System;Formyl peptide receptors bind formyl peptides and many other ligands;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);roles of arrestin dependent recruitment of src kinases in gpcr signaling;GPCR ligand binding;fmlp induced chemokine gene expression in hmc-1 cells;-arrestins in gpcr desensitization;G alpha (i) signalling events;GPCR downstream signalling;Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling (Consensus)

Recessive Scores

pRec
0.194

Intolerance Scores

loftool
0.570
rvis_EVS
1.13
rvis_percentile_EVS
92.26

Haploinsufficiency Scores

pHI
0.0532
hipred
N
hipred_score
0.430
ghis
0.403

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.165

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Fpr1
Phenotype
hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype;

Zebrafish Information Network

Gene name
fpr1
Affected structure
neutrophil activation involved in immune response
Phenotype tag
abnormal
Phenotype quality
disrupted

Gene ontology

Biological process
activation of MAPK activity;complement receptor mediated signaling pathway;chemotaxis;inflammatory response;signal transduction;G protein-coupled receptor signaling pathway;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;phospholipase C-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;nitric oxide mediated signal transduction;cytokine-mediated signaling pathway;neutrophil degranulation
Cellular component
plasma membrane;integral component of membrane;secretory granule membrane;azurophil granule membrane;ficolin-1-rich granule membrane
Molecular function
G protein-coupled receptor binding;G protein-coupled receptor activity;N-formyl peptide receptor activity;scavenger receptor binding;protein binding;RAGE receptor binding